4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-062738
EVP, Research & CSO sold 3,805 shares at $31.27 ($118,966)
- EVP, Research & CSO acquired 3,805 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-12-08 | Option exercise | +3,805 | $1.53 | $5,822 | 27,505 | D: show line 1 in the form |
| Virgin Herbert EVP, Research & CSO | 2020-12-08 | Sale | −3,805 | $31.27 | $118,966 | 23,700 | D: show line 2 in the form |
| Open-market sales · 3,805 sh · avg $31.27 · $118,966 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2020-12-08 | Option exercise · Stock Option (Right to Buy) | −3,805 | 439,095 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…